{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:39:34Z","timestamp":1792683574131,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["In Vitro Cell.Dev.Biol.-Animal"],"DOI":"10.1007\/s11626-026-01249-w","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:49:11Z","timestamp":1792680551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ginsenoside Rg3 attenuates hyperuricemia-associated AKI by upregulating CPT1A and suppressing NLRP3\/Caspase-1\/GSDMD-mediated pyroptosis"],"prefix":"10.1007","author":[{"given":"Na","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dihan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"1249_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s40292-025-00777-y","author":"C Borghi","year":"2025","unstructured":"Borghi C, Piani F, Manolis AL (2025) Comprehensive review on febuxostat for hyperuricemia with gout: insights from current practice and clinical trials. High Blood Press Cardiovasc Prev. https:\/\/doi.org\/10.1007\/s40292-025-00777-y","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"1249_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102973","volume":"69","author":"F Cai","year":"2024","unstructured":"Cai F, Li D, Xie Y et al (2024) Sulfide:quinone oxidoreductase alleviates ferroptosis in acute kidney injury via ameliorating mitochondrial dysfunction of renal tubular epithelial cells. Redox Biol 69:102973. https:\/\/doi.org\/10.1016\/j.redox.2023.102973","journal-title":"Redox Biol"},{"key":"1249_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2019.153111","volume":"66","author":"D Cui","year":"2020","unstructured":"Cui D, Liu S, Tang M et al (2020) Phloretin ameliorates hyperuricemia-induced chronic renal dysfunction through inhibiting NLRP3 inflammasome and uric acid reabsorption. Phytomedicine 66:153111. https:\/\/doi.org\/10.1016\/j.phymed.2019.153111","journal-title":"Phytomedicine"},{"key":"1249_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102006","volume":"46","author":"X Cui","year":"2024","unstructured":"Cui X, Cao C, Li X et al (2024) Succinylation of 14\u20133-3 theta by CPT1A promotes survival and paclitaxel resistance in nasal type extranodal natural killer\/T-cell lymphoma. Transl Oncol 46:102006. https:\/\/doi.org\/10.1016\/j.tranon.2024.102006","journal-title":"Transl Oncol"},{"key":"1249_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01916-y","volume":"9","author":"L Du","year":"2024","unstructured":"Du L, Zong Y, Li H et al (2024) Hyperuricemia and its related diseases: mechanisms and advances in therapy. Signal Transduct Target Ther 9:212. https:\/\/doi.org\/10.1038\/s41392-024-01916-y","journal-title":"Signal Transduct Target Ther"},{"key":"1249_CR6","doi-asserted-by":"publisher","unstructured":"Gafar Abubakir Osman H, Abderahim  A, Ahmed Babiker  MM\u00a0et al (2025) Impact of Urate-lowering agents on renal outcomes in chronic kidney disease: a systematic review. Cureus 17:e89343. https:\/\/doi.org\/10.7759\/cureus.89343","DOI":"10.7759\/cureus.89343"},{"key":"1249_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefroe.2025.501334","volume":"45","author":"M Goicoechea","year":"2025","unstructured":"Goicoechea M, Garc\u00eda-Marina R (2025) Hyperuricemia in patients with chronic kidney disease: when and what to treat. Nefrolog\u00eda (English Edition) 45:501334. https:\/\/doi.org\/10.1016\/j.nefroe.2025.501334","journal-title":"Nefrolog\u00eda (English Edition)"},{"key":"1249_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122813","volume":"351","author":"NT Henedak","year":"2024","unstructured":"Henedak NT, El-Abhar HS, Soubh AA et al (2024) NLRP3 Inflammasome: A central player in renal pathologies and nephropathy. Life Sci 351:122813. https:\/\/doi.org\/10.1016\/j.lfs.2024.122813","journal-title":"Life Sci"},{"key":"1249_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101690","volume":"5","author":"H Hu","year":"2024","unstructured":"Hu H, Li W, Hao Y et al (2024) The SGLT2 inhibitor dapagliflozin ameliorates renal fibrosis in hyperuricemic nephropathy. Cell Rep Med 5:101690. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101690","journal-title":"Cell Rep Med"},{"key":"1249_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118362","volume":"332","author":"X Ji","year":"2024","unstructured":"Ji X, Yu L, Han C et al (2024) Investigating the effects of rare ginsenosides on hyperuricemia and associated sperm damage via nontargeted metabolomics and gut microbiota. J Ethnopharmacol 332:118362. https:\/\/doi.org\/10.1016\/j.jep.2024.118362","journal-title":"J Ethnopharmacol"},{"key":"1249_CR11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1159\/000539496","volume":"10","author":"Y Ji","year":"2024","unstructured":"Ji Y, Hua H, Jia Z et al (2024b) Therapy targeted to the NLRP3 inflammasome in chronic kidney disease. Kidney Dis 10:369\u2013383. https:\/\/doi.org\/10.1159\/000539496","journal-title":"Kidney Dis"},{"key":"1249_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-025-00922-0","volume":"21","author":"H Jia","year":"2026","unstructured":"Jia H, Ma L, Liu J et al (2026) Organelle stress in NLRP3 inflammasome: a central mediator of neurodegenerative diseases. Mol Neurodegener 21:8. https:\/\/doi.org\/10.1186\/s13024-025-00922-0","journal-title":"Mol Neurodegener"},{"key":"1249_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1702234","volume":"16","author":"T Jin","year":"2025","unstructured":"Jin T, Du Y, Liu C et al (2025) Advances in ginsenoside treatment for common kidney diseases: pharmacological evaluation and potential mechanisms. Front Pharmacol 16:1702234. https:\/\/doi.org\/10.3389\/fphar.2025.1702234","journal-title":"Front Pharmacol"},{"key":"1249_CR14","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.celrep.2018.01.030","volume":"22","author":"K Kurmi","year":"2018","unstructured":"Kurmi K, Hitosugi S, Wiese EK et al (2018) Carnitine Palmitoyltransferase 1A Has a Lysine Succinyltransferase Activity. Cell Rep 22:1365\u20131373. https:\/\/doi.org\/10.1016\/j.celrep.2018.01.030","journal-title":"Cell Rep"},{"key":"1249_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.113500","volume":"267","author":"Y Li","year":"2021","unstructured":"Li Y, Hou JG, Liu Z et al (2021) Alleviative effects of 20(R)-Rg3 on HFD\/STZ-induced diabetic nephropathy via MAPK\/NF-\u03baB signaling pathways in C57BL\/6 mice. J Ethnopharmacol 267:113500. https:\/\/doi.org\/10.1016\/j.jep.2020.113500","journal-title":"J Ethnopharmacol"},{"key":"1249_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1160440","volume":"14","author":"K Liang","year":"2023","unstructured":"Liang K (2023) Mitochondrial CPT1A: insights into structure, function, and basis for drug development. Front Pharmacol 14:1160440. https:\/\/doi.org\/10.3389\/fphar.2023.1160440","journal-title":"Front Pharmacol"},{"key":"1249_CR17","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/s41588-025-02077-6","volume":"57","author":"L Liang","year":"2025","unstructured":"Liang L, Kuang X, He Y et al (2025) Alterations in PD-L1 succinylation shape anti-tumor immune responses in melanoma. Nat Genet 57:680\u2013693. https:\/\/doi.org\/10.1038\/s41588-025-02077-6","journal-title":"Nat Genet"},{"key":"1249_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1577669","volume":"13","author":"Y Liu","year":"2025","unstructured":"Liu Y, Liu Y, Yu X et al (2025) CPT1A mediated preservation of mitochondrial inhibits pyroptosis in pancreatic acinar cells. Front Cell Dev Biol 13:1577669. https:\/\/doi.org\/10.3389\/fcell.2025.1577669","journal-title":"Front Cell Dev Biol"},{"key":"1249_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1703560","volume":"16","author":"Y Luo","year":"2025","unstructured":"Luo Y, Long M, Wu X et al (2025) Targeting the NLRP3 inflammasome in kidney disease: molecular mechanisms, pathogenic roles, and emerging small-molecule therapeutics. Front Immunol 16:1703560. https:\/\/doi.org\/10.3389\/fimmu.2025.1703560","journal-title":"Front Immunol"},{"key":"1249_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108463","volume":"26","author":"L Ma","year":"2023","unstructured":"Ma L, Shen R, Jiao J et al (2023) Gasdermin D promotes hyperuricemia-induced renal tubular injury through RIG-I\/caspase-1 pathway. iScience 26:108463. https:\/\/doi.org\/10.1016\/j.isci.2023.108463","journal-title":"iScience"},{"key":"1249_CR21","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140695","volume":"131","author":"V Miguel","year":"2021","unstructured":"Miguel V, Tituana J, Herrero JI et al (2021) Renal tubule Cpt1a overexpression protects from kidney fibrosis by restoring mitochondrial homeostasis. J Clin Invest 131:e140695. https:\/\/doi.org\/10.1172\/JCI140695","journal-title":"J Clin Invest"},{"key":"1249_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2025.101021","volume":"7","author":"DK Ng","year":"2025","unstructured":"Ng DK, Matheson MB, Schwartz GJ et al (2025) Effectiveness of allopurinol on uric acid and pediatric chronic kidney disease severity in the Chronic Kidney Disease in Children Study. Kidney Med 7:101021. https:\/\/doi.org\/10.1016\/j.xkme.2025.101021","journal-title":"Kidney Med"},{"key":"1249_CR23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4078\/jrd.2024.0121","volume":"32","author":"YJ Oh","year":"2025","unstructured":"Oh YJ, Shin JM, Hur JW et al (2025) Association between serum urate, gout and chronic kidney disease: a scoping review of systematic reviews and meta-analyses. J Rheum Dis 32:241\u2013251. https:\/\/doi.org\/10.4078\/jrd.2024.0121","journal-title":"J Rheum Dis"},{"key":"1249_CR24","doi-asserted-by":"publisher","first-page":"5056","DOI":"10.2174\/0929867326666181211094421","volume":"27","author":"J Pan","year":"2020","unstructured":"Pan J, Shi M, Ma L et al (2020) Mechanistic Insights of Soluble Uric Acid-related Kidney Disease. Curr Med Chem 27:5056\u20135066. https:\/\/doi.org\/10.2174\/0929867326666181211094421","journal-title":"Curr Med Chem"},{"key":"1249_CR25","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqz046","volume":"161","author":"IR Schlaepfer","year":"2020","unstructured":"Schlaepfer IR, Joshi M (2020) CPT1A-mediated fat oxidation, mechanisms, and therapeutic potential. Endocrinology 161:bqz046. https:\/\/doi.org\/10.1210\/endocr\/bqz046","journal-title":"Endocrinology"},{"key":"1249_CR26","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1681\/asn.2020040523","volume":"31","author":"M Sellmayr","year":"2020","unstructured":"Sellmayr M, Hernandez Petzsche MR, Ma Q et al (2020) Only hyperuricemia with crystalluria, but not asymptomatic hyperuricemia, drives progression of chronic kidney disease. J Am Soc Nephrol 31:2773\u20132792. https:\/\/doi.org\/10.1681\/asn.2020040523","journal-title":"J Am Soc Nephrol"},{"key":"1249_CR27","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1096\/fj.201901537R","volume":"34","author":"Y Shi","year":"2020","unstructured":"Shi Y, Wang HN, Zheng MJ et al (2020) Ginsenoside Rg3 suppresses the NLRP3 inflammasome activation through inhibition of its assembly. FASEB J 34:208\u2013221. https:\/\/doi.org\/10.1096\/fj.201901537R","journal-title":"FASEB J"},{"issue":"1","key":"1249_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5817348","volume":"2020","author":"HY Su","year":"2020","unstructured":"Su HY, Yang C, Liang D et al (2020) Research advances in the mechanisms of hyperuricemia-induced renal injury. BioMed Res Int 5817348. https:\/\/doi.org\/10.1155\/2020\/5817348","journal-title":"BioMed Res Int"},{"key":"1249_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27031426","volume":"27","author":"Q Sun","year":"2026","unstructured":"Sun Q, Yin L (2026) From multidimensional management to mechanistic insight: a review of interventions for hyperuricemia. Int J Mol Sci 27:1426. https:\/\/doi.org\/10.3390\/ijms27031426","journal-title":"Int J Mol Sci"},{"key":"1249_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26189000","volume":"26","author":"T Takata","year":"2025","unstructured":"Takata T, Mae Y, Hoi S et al (2025) Hyperuricemia in chronic kidney disease: emerging pathophysiology and a novel therapeutic strategy. Int J Mol Sci 26:9000. https:\/\/doi.org\/10.3390\/ijms26189000","journal-title":"Int J Mol Sci"},{"key":"1249_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s10565-025-09994-6","volume":"41","author":"H Tian","year":"2025","unstructured":"Tian H, Ge Y, Yu J et al (2025) CPT1A mediates succinylation of LDHA at K318 site promoteing metabolic reprogramming in NK\/T-cell lymphoma nasal type. Cell Biol Toxicol 41:42. https:\/\/doi.org\/10.1007\/s10565-025-09994-6","journal-title":"Cell Biol Toxicol"},{"key":"1249_CR32","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2024.2427181","volume":"46","author":"J Wang","year":"2024","unstructured":"Wang J, Chen R, Wu K et al (2024) Establishment and optimization of a novel mouse model of hyperuricemic nephropathy. Ren Fail 46:2427181. https:\/\/doi.org\/10.1080\/0886022X.2024.2427181","journal-title":"Ren Fail"},{"key":"1249_CR33","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1080\/0886022x.2022.2036620","volume":"44","author":"M Wang","year":"2022","unstructured":"Wang M, Lin X, Yang X et al (2022) Research progress on related mechanisms of uric acid activating NLRP3 inflammasome in chronic kidney disease. Ren Fail 44:615\u2013624. https:\/\/doi.org\/10.1080\/0886022x.2022.2036620","journal-title":"Ren Fail"},{"key":"1249_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1785","volume":"14","author":"M Wang","year":"2024","unstructured":"Wang M, Wu D, Liao X et al (2024b) CPT1A-IL-10-mediated macrophage metabolic and phenotypic alterations ameliorate acute lung injury. Clin Transl Med 14:e1785. https:\/\/doi.org\/10.1002\/ctm2.1785","journal-title":"Clin Transl Med"},{"key":"1249_CR35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jgr.2023.11.004","volume":"48","author":"W Wang","year":"2024","unstructured":"Wang W, Li K, Xiao W (2024c) The pharmacological role of Ginsenoside Rg3 in liver diseases: a review on molecular mechanisms. J Ginseng Res 48:129\u2013139. https:\/\/doi.org\/10.1016\/j.jgr.2023.11.004","journal-title":"J Ginseng Res"},{"key":"1249_CR36","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s11010-020-03997-z","volume":"476","author":"L Wen","year":"2021","unstructured":"Wen L, Yang H, Ma L et al (2021) The roles of NLRP3 inflammasome-mediated signaling pathways in hyperuricemic nephropathy. Mol Cell Biochem 476:1377\u20131386. https:\/\/doi.org\/10.1007\/s11010-020-03997-z","journal-title":"Mol Cell Biochem"},{"key":"1249_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2023.105514","volume":"167","author":"W Xu","year":"2023","unstructured":"Xu W, Lyu W, Duan C et al (2023) Preparation and bioactivity of the rare ginsenosides Rg3 and Rh2: an updated review. Fitoterapia 167:105514. https:\/\/doi.org\/10.1016\/j.fitote.2023.105514","journal-title":"Fitoterapia"},{"key":"1249_CR38","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1007\/s11064-019-02780-x","volume":"44","author":"Y Yang","year":"2019","unstructured":"Yang Y, Gibson GE (2019) Succinylation links metabolism to protein functions. Neurochem Res 44:2346\u20132359. https:\/\/doi.org\/10.1007\/s11064-019-02780-x","journal-title":"Neurochem Res"},{"key":"1249_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107799","volume":"216","author":"ZW Yao","year":"2025","unstructured":"Yao ZW, Zhu H (2025) Pharmacological mechanisms and drug delivery systems of ginsenoside Rg3: A comprehensive review. Pharmacol Res 216:107799. https:\/\/doi.org\/10.1016\/j.phrs.2025.107799","journal-title":"Pharmacol Res"},{"key":"1249_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242316736","volume":"24","author":"C Zhang","year":"2023","unstructured":"Zhang C, Yu H, Ye J et al (2023) Ginsenoside Rg3 protects against diabetic cardiomyopathy and promotes adiponectin signaling via activation of PPAR-\u03b3. Int J Mol Sci 24:16736. https:\/\/doi.org\/10.3390\/ijms242316736","journal-title":"Int J Mol Sci"},{"key":"1249_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2025.115549","volume":"202","author":"H Zhang","year":"2025","unstructured":"Zhang H, Zhao C, Hong G et al (2025a) Fatty acid oxidation contributed to NLRP3 inflammasome activation caused by N-nitrosamines co-exposure. Food Chem Toxicol 202:115549. https:\/\/doi.org\/10.1016\/j.fct.2025.115549","journal-title":"Food Chem Toxicol"},{"key":"1249_CR42","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1142\/s0192415x21500828","volume":"49","author":"JJ Zhang","year":"2021","unstructured":"Zhang JJ, Zhou YD, Liu YB et al (2021) Protective Effect of 20(R)-Ginsenoside Rg3 Against Cisplatin-Induced Renal Toxicity via PI3K\/AKT and NF-[Formula: see text]B Signaling Pathways Based on the Premise of Ensuring Anticancer Effect. Am J Chin Med 49:1739\u20131756. https:\/\/doi.org\/10.1142\/s0192415x21500828","journal-title":"Am J Chin Med"},{"key":"1249_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-025-04414-7","volume":"26","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, He F, Yu X et al (2025b) Hyperuricemia-induced kidney injury: a narrative review of mechanisms and therapeutic advances. BMC Nephrol 26:629. https:\/\/doi.org\/10.1186\/s12882-025-04414-7","journal-title":"BMC Nephrol"},{"key":"1249_CR44","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7152176","author":"T Zhou","year":"2020","unstructured":"Zhou T, Sun L, Yang S et al (2020) 20(S)-Ginsenoside Rg3 protects kidney from diabetic kidney disease via renal inflammation depression in diabetic rats. J Diabetes Res. https:\/\/doi.org\/10.1155\/2020\/7152176","journal-title":"J Diabetes Res"},{"key":"1249_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155241","volume":"134","author":"JY Zhu","year":"2022","unstructured":"Zhu JY, Chen M, Mu WJ et al (2022) Higd1a facilitates exercise-mediated alleviation of fatty liver in diet-induced obese mice. Metabolism 134:155241. https:\/\/doi.org\/10.1016\/j.metabol.2022.155241","journal-title":"Metabolism"},{"key":"1249_CR46","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s42003-025-07720-w","volume":"8","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Chen S, Su H et al (2025) CPT1A-mediated MFF succinylation promotes stemness maintenance in ovarian cancer stem cells. Commun Biol 8:250. https:\/\/doi.org\/10.1038\/s42003-025-07720-w","journal-title":"Commun Biol"}],"container-title":["In Vitro Cellular & Developmental Biology - Animal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11626-026-01249-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11626-026-01249-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11626-026-01249-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:49:12Z","timestamp":1792680552000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11626-026-01249-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":46,"alternative-id":["1249"],"URL":"https:\/\/doi.org\/10.1007\/s11626-026-01249-w","relation":{},"ISSN":["1071-2690","1543-706X"],"issn-type":[{"value":"1071-2690","type":"print"},{"value":"1543-706X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"12 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors confirm that this study was conducted in compliance with the ethical standards outlined by the International Committee of Medical Journal Editors (ICMJE).","order":1,"name":"Ethics","label":"Ethical compliance","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experimental procedures were performed in accordance with the NIH Guide for the Care and Use of Laboratory Animals (revised 2011) and were approved by the Ethical Committee of Changchun Humanities and Sciences College (Approval No. 20250176). Male SPF C57BL\/6 mice (6\u20138\u00a0wk old) were obtained from Beijing Vital River Laboratory Animal Technology Co., Ltd. (License No. SCXK (Beijing) 2023\u20110008). All efforts were made to minimize animal suffering, and euthanasia was performed by intraperitoneal injection of pentobarbital sodium (200\u00a0mg\/kg) at the end of the experiments.","order":2,"name":"Ethics","label":"Animal studies","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The human proximal tubule epithelial cell line (HK\u20112) was purchased from Procell. No primary human materials or tissues were obtained directly from patients or volunteers; therefore, informed consent and institutional review board approval for human subjects were not applicable.","order":3,"name":"Ethics","label":"Cell lines","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":6,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}